The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from CNW Group

Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors

Wednesday, May 15, 2013

Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors

20:16 EDT Wednesday, May 15, 2013

LAVAL, Quebec, May 15, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr. Laurence Paul has resigned from Valeant's Board of Directors due to expanded business, philanthropic, and personal commitments. Dr. Paul was originally elected to Biovail Corporation's Board of Directors in June 2002 where he served in several capacities, including heading at various times the audit and compensation committees and multiple special committees including the one that oversaw Biovail's side of the merger with Valeant in September 2010. Since the merger, Dr. Paul has been a member of the Nominating and Corporate Governance Committee, the Operations Committee and the Compensation Committee and has been a key member of and previously headed the Finance and Transactions Committee.

"We want to thank Larry for more than a decade of service to the Company, first at Biovail and then, as part of the new Valeant Board," stated J. Michael Pearson, chairman and chief executive officer. "Larry has been a superb Board member for Valeant, investing his valuable time, talent, and passion to help transform Biovail and Valeant into a leading pharmaceutical company. Larry's wise counsel will be missed."

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

SOURCE: Valeant Pharmaceuticals International, Inc.

For further information:

http://www.valeant.com

http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections